Clinical Trials Sponsored by Therapeutic Advances in Childhood Leukemia Consortium
Total 23 results
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Myelogenous LeukemiaUnited States, Canada, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumNot yet recruitingNeurofibromatosis 1 | JMML | Leukemia, Juvenile Myelomonocytic | JCML | CBL Syndrome
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Lymphoblastic LeukemiaUnited States, Australia, Canada, Brazil
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedRelapsed Acute Lymphoblastic Leukemia | Relapsed Acute Myelogenous LeukemiaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumRecruitingLymphoma, B-Cell | Hodgkin Lymphoma | Lymphoblastic Lymphoma | Lymphoma, T-Cell | AML | Hematologic Malignancy | MDS | Acute Undifferentiated Leukemia | ALL | Mixed Phenotype Acute Leukemia | BPDCNUnited States, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedAcute Lymphoblastic Leukemia | Precursor B-Cell Lymphoblastic Leukemia | Precursor T-Cell Lymphoblastic LeukemiaUnited States, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedRelapsed Acute Lymphoblastic Leukemia | Allergy to PEG e.Coli Asparaginase | Allergy to Native e.Coli AsparaginaseUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumAbbottTerminatedAcute Lymphoblastic Leukemia | Relapsed Pediatric ALL | Recurrent Pediatric ALL | Refractory Pediatric ALLUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumNovartisCompletedNon-Hodgkin's Lymphoma | Lymphoblastic Leukemia, Acute, Childhood | Hodgkin's Disease | Myelogenous Leukemia, Acute, ChildhoodUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGlaxoSmithKline; NovartisTerminatedRelapsed T-Cell Acute Lymphoblastic Leukemia | Relapsed T-Cell Lymphoblastic LymphomaUnited States, France, Canada, Australia, Austria, Italy, Netherlands
-
Etan OrgelTherapeutic Advances in Childhood Leukemia ConsortiumRecruitingObesity | B-cell Acute Lymphoblastic LeukemiaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumBristol-Myers SquibbActive, not recruitingAML, ChildhoodUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumSpectrum Pharmaceuticals, IncRecruitingLymphoblastic Leukemia, Acute, Childhood | ALL, Childhood | Lymphoblastic Leukemia, AcuteUnited States, Australia, Canada
-
Therapeutic Advances in Childhood Leukemia ConsortiumEnzon Pharmaceuticals, Inc.TerminatedLymphoblastic Leukemia, Acute, Childhood | Leukemia, Lymphoblastic, Acute | Lymphoblastic Leukemia, Acute | Leukemia, Lymphoblastic, Acute, T CellUnited States, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumAmbit Biosciences CorporationCompletedLymphoblastic Leukemia, Acute, Childhood | Myelogenous Leukemia, Acute, ChildhoodUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedRelapsed Acute Myelogenous LeukemiaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedMinimal Residual Disease | Leukemia, Lymphoblastic, Acute | Leukemia, Myelogenous, AcuteUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Leukemia Lymphoblastic, Acute | Neoplasm RecurrentUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGateway for Cancer ResearchCompletedLymphoblastic Leukemia, Acute, Childhood | Myelogenous Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumTakeda; Children's Hospital Los AngelesActive, not recruitingLymphoblastic Leukemia, Acute, Childhood | ALL, Childhood | Lymphoblastic Lymphoma, ChildhoodUnited States, Australia
-
Elucida OncologyTherapeutic Advances in Childhood Leukemia and Lymphoma (TACL)WithdrawnAcute Myeloid Leukemia | AML, Childhood | Relapsed Pediatric AML | Refractory Pediatric AML
-
AmgenInnovative Therapies For Children with Cancer Consortium; Therapeutic Advances...Active, not recruitingAcute Lymphoblastic Leukemia (ALL)Spain, United Kingdom, United States, Korea, Republic of, Czechia, France, Russian Federation, Saudi Arabia, Thailand, Canada, Italy, Singapore, Turkey, Taiwan, Portugal, Poland, Romania, Brazil, Australia, Greece, Argentina, Mexico, Austr... and more